Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Current Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Current Liabilities -----

What is the latest Current Liabilities ratio of GLAND PHARMA ?

The latest Current Liabilities ratio of GLAND PHARMA is - based on Mar2026 Consolidated results.
Year Current Liabilities
Mar2026-
Mar2025-
Mar2024-
Mar2023-
Mar2022-

How is Current Liabilities of GLAND PHARMA Trending?

Years Current Liabilities % Change
Mar2026 -
0
Mar2025 -
0
Mar2024 -
0
Mar2023 -
0
Mar2022 - -

Compare Current Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹52,102.1 Cr 2.7% 8.4% 66% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,122.0 Cr 0.7% -0.3% 3.2% Stock Analytics
DIVIS LABORATORIES ₹266,424.0 Cr 4% 8.9% 54.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,914.0 Cr 3.6% -0.5% 28.8% Stock Analytics
DR REDDYS LABORATORIES ₹114,599.0 Cr 2.5% 13.6% 9.4% Stock Analytics
CIPLA ₹113,112.0 Cr 3.2% 5% -11.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

2.7%

8.4%

66%

SENSEX

5.5%

7.5%

-8.7%


You may also like the below Video Courses